The Australian Centre for Translational Breast Cancer Research: From Discovery to Better Health Outcomes

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

TransBCR will implement a collaborative multidisciplinary research program to help fast track the clinical translation of promising laboratory discoveries in breast cancer. To overcome existing roadblocks, we will carry out early phase clinical trials of novel anti-breast cancer drugs linked to suitable diagnostic tests that help select the right therapy for individual cancer patients. Our goal is to help inform the swift delivery of cost-effective personalised medicine in breast cancer.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2017

Funding Scheme: Centres of Research Excellence

Funding Amount: $2,619,075.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Solid Tumours

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

anticancer drug | biomarkers | breast cancer | cancer biology | cancer chemotherapy | cancer genetics | clinical trial | health economics | training